StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3046% below fair value
$24.66−0.19 (-0.76%)

Close on Nov 13, 2026Market cap $678.53MP/E –Yield –

Fulgent Genetics operating margin

Operating margin is operating income as a percentage of revenue.

Fulgent Genetics's operating margin for the twelve months ending Sep 30, 2026 was -39.2%. For fiscal 2025 it was -28.2%, against -26.1% the year before. The highest annual figure on record is 68.8% in fiscal 2020.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-28.2%−2.2
FY2024Dec 31, 2024-26.1%+41.5
FY2023Dec 31, 2023-67.6%−96.4
FY2022Dec 31, 202228.8%−39.3
FY2021Dec 31, 202168.1%−0.7
FY2020Dec 31, 202068.8%+70.1
FY2019Dec 31, 2019-1.3%+22.4
FY2018Dec 31, 2018-23.7%−5.2
FY2017Dec 31, 2017-18.6%−23.6
FY2016Dec 31, 20165.0%+57.4
FY2015Dec 31, 2015-52.3%+25.1
FY2014Dec 31, 2014-77.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-24.9%−6.7
Q2 FY2026Jun 30, 2026-42.2%−18.1
Q1 FY2026Mar 31, 2026-48.7%−21.7
Q4 FY2025Dec 31, 2025-43.5%−22.3
Q3 FY2025Sep 30, 2025-18.3%+5.5
Q2 FY2025Jun 30, 2025-24.1%+2.5
Q1 FY2025Mar 31, 2025-26.9%+6.9
Q4 FY2024Dec 31, 2024-21.2%+193.2
Q3 FY2024Sep 30, 2024-23.8%−24.1
Q2 FY2024Jun 30, 2024-26.6%+2.6
Q1 FY2024Mar 31, 2024-33.8%+3.7
Q4 FY2023Dec 31, 2023-214.3%−160.4
Q3 FY2023Sep 30, 20230.3%−0.1
Q2 FY2023Jun 30, 2023-29.2%−39.4
Q1 FY2023Mar 31, 2023-37.5%−100.6
Q4 FY2022Dec 31, 2022-54.0%−113.9
Q3 FY2022Sep 30, 20220.3%−69.6
Q2 FY2022Jun 30, 202210.2%−54.2
Q1 FY2022Mar 31, 202263.1%−11.2
Q4 FY2021Dec 31, 202159.9%−16.6
Q3 FY2021Sep 30, 202169.9%+7.4
Q2 FY2021Jun 30, 202164.4%+49.1
Q1 FY2021Mar 31, 202174.3%+99.0
Q4 FY2020Dec 31, 202076.6%+81.5
Q3 FY2020Sep 30, 202062.5%+47.9
Q2 FY2020Jun 30, 202015.3%+11.8
Q1 FY2020Mar 31, 2020-24.7%+9.3
Q4 FY2019Dec 31, 2019-4.9%+13.3
Q3 FY2019Sep 30, 201914.6%+29.6
Q2 FY2019Jun 30, 20193.5%+22.0
Q1 FY2019Mar 31, 2019-33.9%+13.2
Q4 FY2018Dec 31, 2018-18.1%+30.2
Q3 FY2018Sep 30, 2018-15.0%+17.8
Q2 FY2018Jun 30, 2018-18.5%−15.3
Q1 FY2018Mar 31, 2018-47.2%−51.3
Q4 FY2017Dec 31, 2017-48.4%−69.9
Q3 FY2017Sep 30, 2017-32.9%–
Q2 FY2017Jun 30, 2017-3.2%–
Q1 FY2017Mar 31, 20174.1%–
Q4 FY2016Dec 31, 201621.5%–

More Fulgent Genetics figures

See a number that looks wrong?